Skip to main content
SpringerLink
Log in

Current Risk Scores for the Establishment of the Best Myocardial Revascularization Methods

  • Chapter
  • First Online:
Coronary Graft Failure

  • 1041 Accesses

Abstract

Graft failure is an unresolved issue although there is much progress in this area. Anatomical, clinical, and functional quantification systems of coronary lesions that require myocardial revascularization aim to establish the indication criteria and criteria for major adverse events due to this procedure. SYNTAX score (SYNergy between PCI with TAXUS™ and Cardiac Surgery), the simple additive and full logistic EuroSCORE (European System for Cardiac Operative Risk Evaluation), global risk score, or others, have proven prediction in multiple trials and meta-analyses. Moreover, the SYNTAX score in all its variants has calculable value for interventional and surgery myocardial revascularization using clinical and functional lesion quantification based on the data from a study with 855 patients. Furthermore, EuroSCORE is used in the forecasting of major adverse events secondary to surgical myocardial revascularization with established relevance. All the other scoring systems aim to complete the most commonly utilized scores so that the most efficient myocardial revascularization procedure to be appropriate is selected. On the other hand, comparative studies between these scores demonstrate that the combination of various scores has the best prediction ability, especially when the quantification algorithm of score is based on the clinical data of patient and, nonetheless, the angiographic criterion. The significance of these scores consists in the choice of myocardial revascularization procedure with the lowest major adverse events and with the longest permeability duration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Caggegi A, Capodanno C, Tamburino C, Tamburino C. Assessing patients for left main percutaneous coronary intervention – considerations and practicalities of risk Scores. J Interven Cardiol. 2012;7(1):24–7.

    Google Scholar 

  2. Parker JO, Di Giorgi S, West RO. Selective coronary arteriography: arteriographic patterns in coronary heart disease. Can Med Assoc J. 1966;95(7):291–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Friesinger GC, Page EE, Ross RS. Prognostic significance of coronary arteriography. Trans Assoc Am Physicians. 1970;83:78–92.

    CAS  PubMed  Google Scholar 

  4. Oberman A, Jones WB, Riley CP, Reeves TJ, Sheffield LT, Turner ME. Natural history of coronary artery disease. Bull NY Acad Med. 1972;48(9):1109–25.

    Google Scholar 

  5. Bruschke AV, Proudfit WL, Sones Jr FM. Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5–9 years. I. Arterographic correlations. Circulation. 1973;47(6):1147–53.

    Article  CAS  PubMed  Google Scholar 

  6. Brymer JF, Buter TH, Walton Jr JA, Willis 3rd PW. A natural history study of the prognostic role of coronary arteriography. Am Heart J. 1974;88(2):139–43.

    Article  CAS  PubMed  Google Scholar 

  7. Gensini GGMD. The coronary artery disease scoring and retrieval system. In: Gensini GGMD, editor. Coronary arteriography. Mount Kisco/New York: Futura Publishing Co; 1975. p. 271–4.

    Google Scholar 

  8. Brandt PW, Partridge JB, Wattie WJ. Coronary arteriography; method of presentation of the arteriogram report and a scoring system. Clin Radiol. 1977;28(4):361–5.

    Article  CAS  PubMed  Google Scholar 

  9. Dash H, Johnson RA, Dinsmore RE, Harthorne JW. Cardiomyopathic syndrome due to coronary artery disease. I: Relation to angiographic extent of coronary disease and to remote myocardial infarction. Br Heart J. 1977;39(7):733–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Proudfit WL, Bruschke AV, Sones Jr FM. Natural history of obstructive coronary artery disease: ten-year study of 601 nonsurgical cases. Prog Cardiovasc Dis. 1978;21(1):53–78.

    Article  CAS  PubMed  Google Scholar 

  11. Jenkins PJ, Harper RW, Nestel PJ. Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J. 1978;2(6134):388–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Harris PJ, Behar VS, Conley MJ, Harrell Jr FE, Lee KL, Peter RH, Kong Y, Rosati RA. The prognostic significance of 50 % coronary stenosis in medically treated patients with coronary artery disease. Circulation. 1980;62(2):240–8.

    Article  CAS  PubMed  Google Scholar 

  13. Lee JT, Ideker RE, Reimer KA. Myocardial infarct size and location in relation to the coronary vascular bed at risk in man. Circulation. 1981;64(3):526–34.

    Article  CAS  PubMed  Google Scholar 

  14. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation. 1981;63(2):285–99.

    Article  CAS  PubMed  Google Scholar 

  15. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, Marcus ML. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med. 1984;310(13):819–24.

    Article  CAS  PubMed  Google Scholar 

  16. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 1985;71(5):881–8.

    Article  CAS  PubMed  Google Scholar 

  17. Califf RM, Phillips 3rd HR, Hindman MC, Mark DB, Lee KL, Behar VS, Johnson RA, Pryor DB, Rosati RA, Wagner GS, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5(5):1055–63.

    Article  CAS  PubMed  Google Scholar 

  18. Hamsten A, Walldius G, Szamosi A, Dahlen G, de Faire U. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation. 1986;73(6):1097–110.

    Article  CAS  PubMed  Google Scholar 

  19. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King 3rd SB, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters Jr WL, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1988;78(2):486–502.

    Article  CAS  PubMed  Google Scholar 

  20. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J. 1990;119(6):1262–7.

    Article  CAS  PubMed  Google Scholar 

  21. Ryan TJ, Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82(4):1193–202.

    Google Scholar 

  22. Alderman EL, Stadius M. The angiographic definitions of the Bypass Angioplasty Revascularization Investigation. Coron Artery Dis. 1992;3:1189–207.

    Google Scholar 

  23. Seiler C, Kirkeeide RL, Gould KL. Measurement from arteriograms of regional myocardial bed size distal to any point in the coronary vascular tree for assessing anatomic area at risk. J Am Coll Cardiol. 1993;21(3):783–97.

    Article  CAS  PubMed  Google Scholar 

  24. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–27.

    PubMed  Google Scholar 

  25. Graham MM, Faris PD, Ghali WA, Galbraith PD, Norris CM, Badry JT, Mitchell LB, Curtis MJ, Knudtson ML, APPROACH Investigators (Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease). Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Heart J. 2001;142(2):254–61.

    Article  CAS  PubMed  Google Scholar 

  26. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213–24.

    Article  CAS  PubMed  Google Scholar 

  27. Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, MacCarthy PA, van’t Veer M, Pijls NHJ. Angiographic versus functional severity of coronary artery stenoses in the fame study: Fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55:2816–21.

    Article  PubMed  Google Scholar 

  28. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734–44; discussion 744–5.

    Article  PubMed  Google Scholar 

  29. Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes Jr DR, Mack M, Feldman T, Morice MC, Ståhle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381(9867):639–50.

    Article  PubMed  Google Scholar 

  30. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619.

    Article  PubMed  Google Scholar 

  31. Capodanno D. Lost in calculation: the clinical SYNTAX score goes logistic. Eur Heart J. 2012;33(24):3008–10.

    Article  PubMed  Google Scholar 

  32. Farooq V, Brugaletta S, Serruys PW. Utilizing risk scores in determining the optimal revascularization strategy for complex coronary artery disease. Curr Cardiol Rep. 2011;13(5):415–23.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Escaned J, Serruys PW. Coronary stenosis imaging, structure and physiology. Toulouse: PCR Publishing; 2011.

    Google Scholar 

  34. Khattab AA, Hamm CW, Senges J, Toelg R, Geist V, Bonzel T, Kelm M, Levenson B, Nienaber CA, Pfannebecker T, Sabin G, Schneider S, Tebbe U, Richardt G, German Cypher Registry. Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry). Am J Cardiol. 2008;101(4):477–82.

    Article  PubMed  Google Scholar 

  35. Valgimigli M, Dawkins K, Macaya C, de Bruyne B, Teiger E, Fajadet J, Gert R, De Servi S, Ramondo A, Wittebols K, Stoll HP, Rademaker TA, Serruys PW. Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial. J Am Coll Cardiol. 2007;49(4):431–41.

    Article  CAS  PubMed  Google Scholar 

  36. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv. 2009;2(4):302–8.

    Article  PubMed  Google Scholar 

  37. Kappetein AP, Feldman TE, Mack MJ, Morice MC, Holmes DR, Ståhle E, Dawkins KD, Mohr FW, Serruys PW, Colombo A. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;32(17):2125–34.

    Article  PubMed  Google Scholar 

  38. Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009;5(1):50–6.

    Article  PubMed  Google Scholar 

  39. Fearon WF. Functional Syntax score. Presented at: Left Main Coronary Interventions Course; February 14, 2011; New York.

    Google Scholar 

  40. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79(6 Pt 2):I3–12.

    CAS  PubMed  Google Scholar 

  41. Singh M, Rihal CS, Lennon RJ, Spertus J, Rumsfeld JS, Holmes Jr DR. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. Mayo Clin Proc. 2007;82(6):701–8.

    Article  PubMed  Google Scholar 

  42. Singh M, Gersh BJ, Li S, Rumsfeld JS, Spertus JA, O’Brien SM, Suri RM, Peterson ED. Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery. Circulation. 2008;117(3):356–62.

    Article  PubMed  Google Scholar 

  43. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16(1):9–13.

    Article  CAS  PubMed  Google Scholar 

  44. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J. 2003;24(9):881–2.

    Article  CAS  PubMed  Google Scholar 

  45. Kim YH, Ahn JM, Park DW, Lee BK, Lee CW, Hong MK, Kim JJ, Park SW, Park SJ. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol. 2006;98(12):1567–70.

    Article  PubMed  Google Scholar 

  46. Romagnoli E, Burzotta F, Trani C, Siviglia M, Biondi-Zoccai GG, Niccoli G, Leone AM, Porto I, Mazzari MA, Mongiardo R, Rebuzzi AG, Schiavoni G, Crea F. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart. 2009;95(1):43–8.

    Article  CAS  PubMed  Google Scholar 

  47. Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv. 2010;3(6):612–23.

    Article  PubMed  Google Scholar 

  48. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Torracca L, van Es GA, Leadley K, Dawkins KD, Mohr F. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121(24):2645–53.

    Article  CAS  PubMed  Google Scholar 

  49. Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F, Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation. 2008;118(23):2374–81.

    Article  PubMed  Google Scholar 

  50. Onuma Y, Girasis C, Piazza N, Garcia-Garcia HM, Kukreja N, Garg S, Eindhoven J, Cheng JM, Valgimigli M, van Domburg R, Serruys PW, Interventional Cardiologists at Thoraxcenter 2000–2005. Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv. 2010;3(6):584–94.

    Article  PubMed  Google Scholar 

  51. Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, Shaw RE, Roe MT, Ho KK, Klein LW, Krone RJ, Weintraub WS, Brindis RG, Rumsfeld JS, Spertus JA, NCDR Registry Participants. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55(18):1923–32.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119(24):3053–61.

    Article  PubMed  Google Scholar 

  53. Ranucci M, Castelvecchio S, Surgical and Clinical Outcome Research (SCORE) Group. The ACEF score one year after: a skeleton waiting for muscles, skin, and internal organs. EuroIntervention. 2010;6(5):549–53.

    Article  PubMed  Google Scholar 

  54. Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Goedhart D, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‘All-Comers’ LEADERS trial. Circ Cardiovasc Interv. 2011;4(1):47–56.

    Article  CAS  PubMed  Google Scholar 

  55. O’Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, Maloney CT, Nowicki ER, Levy DG, Tryzelaar JF, Hernandez F, et al. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 1992;85(6):2110–8.

    Article  PubMed  Google Scholar 

  56. Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, Higgins RS, Isom OW, Smith CR, Jones RH. Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol. 2006;47(3):661–8.

    Article  PubMed  Google Scholar 

  57. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson Jr TB, Grover FL, Edwards FH, Society of Thoracic Surgeons. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75(6):1856–64. discussion 1864–5.

    Article  PubMed  Google Scholar 

  58. Shahian DM, O’Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP, Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2–22.

    Article  PubMed  Google Scholar 

  59. Ad N, Barnett SD, Speir AM. The performance of the EuroSCORE and the Society of Thoracic Surgeons mortality risk score: the gender factor. Interact Cardiovasc Thorac Surg. 2007;6(2):192–5.

    Article  PubMed  Google Scholar 

  60. Madan P, Elayda MA, Lee VV, Wilson JM. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score. Am Heart J. 2008;155(6):1068–74.

    Article  PubMed  Google Scholar 

  61. Wu C, Hannan EL, Walford G, Ambrose JA, Holmes Jr DR, King 3rd SB, Clark LT, Katz S, Sharma S, Jones RH. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006;47(3):654–60.

    Article  PubMed  Google Scholar 

  62. Chakravarty T, Buch MH, Naik H, White AJ, Doctor N, Schapira J, Mirocha JM, Fontana G, Forrester JS, Makkar R. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol. 2011;107(3):360–6.

    Article  PubMed  Google Scholar 

  63. Garg S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, Serruys PW, ARTS-II Investigators. A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score. Circ Cardiovasc Interv. 2010;3(4):317–26.

    Article  PubMed  Google Scholar 

  64. Chen SL, Chen JP, Mintz G, Xu B, Kan J, Ye F, Zhang J, Sun X, Xu Y, Jiang Q, Zhang A, Stone GW. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting. JACC Cardiovasc Interv. 2010;3(6):632–41.

    Article  PubMed  Google Scholar 

  65. Capodanno D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, Capranzano P, Ussia G, Di Salvo ME, La Manna A, Tamburino C. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv. 2011;4(3):287–97.

    Article  PubMed  Google Scholar 

  66. Capodanno D, Miano M, Cincotta G, Caggegi A, Ruperto C, Bucalo R, Sanfilippo A, Capranzano P, Tamburino C. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J. 2010;159(1):103–9.

    Article  PubMed  Google Scholar 

  67. Biancari F, Vasques F, Mikkola R, Martin M, Lahtinen J, Heikkinen J. Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery. Ann Thorac Surg. 2012;93(6):1930–5.

    Article  PubMed  Google Scholar 

  68. Chalmers J, Pullan M, Fabri B, McShane J, Shaw M, Mediratta N, Poullis M. Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur J Cardiothorac Surg. 2013;43(4):688–94.

    Article  PubMed  Google Scholar 

  69. Grant SW, Hickey GL, Dimarakis I, Trivedi U, Bryan A, Treasure T, Cooper G, Pagano D, Buchan I, Bridgewater B. How does EuroSCORE II perform in UK cardiac surgery; an analysis of 23 740 patients from the Society for Cardiothoracic Surgery in Great Britain and Ireland National Database. Heart. 2012;98(21):1568–72.

    Article  PubMed  Google Scholar 

  70. Ellis SG, Guetta V, Miller D, Whitlow PL, Topol EJ. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: an analysis of results from 10,907 lesions and proposal for new classification scheme. Circulation. 1999;100(19):1971–6.

    Article  CAS  PubMed  Google Scholar 

  71. Krone RJ, Shaw RE, Klein LW, Block PC, Anderson HV, Weintraub WS, Brindis RG, McKay CR, ACC-National Cardiovascular Data Registry. Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current “stent era” of coronary interventions (from the ACC-National Cardiovascular Data Registry). Am J Cardiol. 2003;92(4):389–94.

    Article  PubMed  Google Scholar 

  72. Zaacks SM, Allen JE, Calvin JE, Schaer GL, Palvas BW, Parrillo JE, Klein LW. Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol. 1998;82(1):43–9.

    Article  CAS  PubMed  Google Scholar 

  73. Seshadri N, Whitlow PL, Acharya N, Houghtaling P, Blackstone EH, Ellis SG. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation. 2002;106(18):2346–50.

    Article  PubMed  Google Scholar 

  74. Myler RK, Shaw RE, Stertzer SH, Hecht HS, Ryan C, Rosenblum J, Cumberland DC, Murphy MC, Hansell HN, Hidalgo B. Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol. 1992;19(7):1641–52.

    Article  CAS  PubMed  Google Scholar 

  75. Tan K, Sulke N, Taub N, Sowton E. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol. 1995;25(4):855–65.

    Article  CAS  PubMed  Google Scholar 

  76. Farooq V, Brugaletta S, Serruys PW. Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention. Heart. 2011;97(23):1902–13.

    Article  PubMed  Google Scholar 

  77. Goto K, Lansky AJ, Fahy M, Cristea E, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Mehran R, Stone GW. Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy. Circulation. 2010;121(7):853–62.

    Article  PubMed  Google Scholar 

  78. Perera D, Stables R, Booth J, Thomas M, Redwood S, BCIS-1 Investigators. The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design. Am Heart J. 2009;158(6):910–916.e2.

    Article  PubMed  Google Scholar 

  79. Morton GD, De Silva K, Ishida M, Chiribiri A, Indermuehle A, Schuster A, Redwood S, Nagel E, Perera D. Validation of the BCIS-1 myocardial jeopardy score using cardiac magnetic resonance perfusion imaging. Clin Physiol Funct Imaging. 2013;33(2):101–8.

    Article  PubMed  Google Scholar 

  80. Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K. Stoll HP; ARTS II Investigators. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol. 2010;55(11):1093–101.

    Article  PubMed  Google Scholar 

  81. Davierwala P, Mohr FW. Five years after the SYNTAX trial: what have we learnt? Eur J Cardiothorac Surg. 2013;44(1):1–3.

    Article  PubMed  Google Scholar 

  82. Garg S, Stone GW, Kappetein AP, Sabik 3rd JF, Simonton C, Serruys PW. Clinical and angiographic risk assessment in patients with left main stem lesions. JACC Cardiovasc Interv. 2010;3(9):891–901.

    Article  PubMed  Google Scholar 

  83. Pijls NH, Van Gelder B, Van der Voort P, Peels K, Bracke FA, Bonnier HJ, el Gamal MI. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92(11):3183–93.

    Article  CAS  PubMed  Google Scholar 

  84. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, Stella PR, Boersma E, Bartunek J, Koolen JJ, Wijns W. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103(24):2928–34.

    Article  CAS  PubMed  Google Scholar 

  85. Pijls NH, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B, Fractional Flow Reserve (FFR) Post-Stent Registry Investigators. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation. 2002;105(25):2950–4.

    Article  PubMed  Google Scholar 

  86. Nam CW, Mangiacapra F, Entjes R, Chung IS, Sels JW, Tonino PA, De Bruyne B, Pijls NH, Fearon WF, FAME Study Investigators. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol. 2011;58(12):1211–8.

    Article  PubMed  Google Scholar 

  87. Shahian DM, O’Brien SM, Sheng S, Grover FL, Mayer JE, Jacobs JP, Weiss JM, Delong ER, Peterson ED, Weintraub WS, Grau-Sepulveda MV, Klein LW, Shaw RE, Garratt KN, Moussa ID, Shewan CM, Dangas GD, Edwards FH. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation. 2012;125(12):1491–500.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, Kolm P, Zhang Z, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Shewan CM, Garratt KN, Moussa ID, Dangas GD, Edwards FH. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012;366(16):1467–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Farooq V, Vergouwe Y, Räber L, Vranckx P, Garcia-Garcia H, Diletti R, Kappetein AP, Morel MA, de Vries T, Swart M, Valgimigli M, Dawkins KD, Windecker S, Steyerberg EW, Serruys PW. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J. 2012;33(24):3098–104.

    Article  PubMed  Google Scholar 

  90. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes Jr DR, Morel MA, Van Dyck N, Houle VM, Dawkins KD, Serruys PW. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629–38.

    Article  PubMed  Google Scholar 

  91. Valgimigli M, van Mieghem CA, Ong AT, Aoki J, Granillo GA, McFadden EP, Kappetein AP, de Feyter PJ, Smits PC, Regar E, Van der Giessen WJ, Sianos G, de Jaegere P, Van Domburg RT, Serruys PW. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005 Mar 22;111(11):1383–9.

    Google Scholar 

  92. Toumpoulis IK, Anagnostopoulos CE, DeRose JJ, Swistel DG. European system for cardiac operative risk evaluation predicts long-term survival in patients with coronary artery bypass grafting. Eur J Cardiothorac Surg. 2004;25(1):51–8.

    Article  PubMed  Google Scholar 

  93. Toumpoulis IK, Anagnostopoulos CE, Swistel DG, DeRose Jr JJ. Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery? Eur J Cardiothorac Surg. 2005;27(1):128–33.

    Article  PubMed  Google Scholar 

  94. De Maria R, Mazzoni M, Parolini M, Gregori D, Bortone F, Arena V, Parodi O. Predictive value of EuroSCORE on long term outcome in cardiac surgery patients: a single institution study. Heart. 2005;91(6):779–84.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Farooq V, Brugaletta S, Serruys PW. The SYNTAX score and SYNTAX-based clinical risk scores. Semin Thorac Cardiovasc Surg. 2011;23(2):99–105.

    Article  PubMed  Google Scholar 

  96. Michel P, Roques F, Nashef SA, EuroSCORE Project Group. Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothorac Surg. 2003;23(5):684–7. discussion 687.

    Article  PubMed  Google Scholar 

  97. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med. 2009;122(2):152–61.

    Article  PubMed  Google Scholar 

  98. Khan A, et al. Evaluation of EuroSCORE II for elective isolated CABG Patients first time. Cardiothorac Surg. 2013;8 Suppl 1:72.

    Article  Google Scholar 

  99. Osnabrugge RL, Speir AM, Head SJ, Fonner CE, Fonner E, Kappetein AP, Rich JB. Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2014;46(3):400–8. discussion 408.

    Article  PubMed  Google Scholar 

  100. Thalji NM, Suri RM, Greason KL, Schaff HV. Risk assessment methods for cardiac surgery and intervention. Nat Rev Cardiol. 2014;11(12):704–14.

    Article  PubMed  Google Scholar 

  101. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2010;38(Suppl):S1–S52.

    Google Scholar 

  102. Gogbashian A, Sedrakyan A, Treasure T. EuroSCORE: a systematic review of international performance. Eur J Cardiothorac Surg. 2004;25(5):695–700. Erratum in Eur J Cardiothorac Surg. 2004 Aug;26(2):463.

    Article  CAS  PubMed  Google Scholar 

  103. Gomez-Lara J, Roura G, Blasco-Lucas A, Ortiz D, Sbraga F, Romaguera R, Ferreiro JL, Teruel L, Sanchez-Elvira G, Homs S, Marcano A, Alegre O, González-Costello J, Gomez-Hospital JA, Fontanillas C, Cequier A. Global risk score for choosing the best revascularization strategy in patients with unprotected left main stenosis. J Invasive Cardiol. 2013;25(12):650–8.

    PubMed  Google Scholar 

  104. Wu C, Camacho FT, Wechsler AS, Lahey S, Culliford AT, Jordan D, Gold JP, Higgins RS, Smith CR, Hannan EL. Risk score for predicting long-term mortality after coronary artery bypass graft surgery. Circulation. 2012;125(20):2423–30.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Iqbal J, Vergouwe Y, Bourantas CV, Klaveren DV, Zhang YJ, Campos CM, García-García HM, Morel MA, Valgimigli M, Windecker S, Steyerberg EW, Serruys PW. Predicting 3-year mortality after percutaneous coronary intervention: updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials. JACC Cardiovasc Interv. 2014;7(5):464–70.

    Article  PubMed  Google Scholar 

  106. Weber FD, Schneider H, Wiemer M, Pfannebecker T, Tebbe U, Hamm CW, Senges J, Schneider S, Nienaber CA. Sirolimus eluting stent (Cypher) in patients with diabetes mellitus: results from the German Cypher Stent Registry. Clin Res Cardiol. 2008;97(2):105–9.

    Article  PubMed  Google Scholar 

  107. Mack MJ, Banning AP, Serruys PW, Morice MC, Taeymans Y, Van Nooten G, Possati G, Crea F, Hood KL, Leadley K, Dawkins KD, Kappetein AP. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg. 2011;92(6):2140–6.

    Article  PubMed  Google Scholar 

  108. Hood KL, Leadley K, Dawkins KD, Kappetein AP. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg. 2011;92(6):2140–6.

    Article  PubMed  Google Scholar 

  109. Marso SP, Ellis SG, Tuzcu M, Whitlow PL, Franco I, Raymond RE, Topol EJ. The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics. J Am Coll Cardiol. 1999;33(5):1269–77.

    Article  CAS  PubMed  Google Scholar 

  110. Mercado N, Brugts JJ, Ix JH, Shlipak MG, Dixon SR, Gersh BJ, Lemos PA, Guarneri M, Teirstein PS, Wijns W, Serruys PW, Boersma E, O’Neill WW. Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial). Am J Cardiol. 2008;102(9):1151–5.

    Article  CAS  PubMed  Google Scholar 

  111. Farooq V, Serruys PW, Bourantas CV, Zhang Y, Muramatsu T, Feldman T, Holmes DR, Mack M, Morice MC, Ståhle E, Colombo A, de Vries T, Morel MA, Dawkins KD, Kappetein AP, Mohr FW. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score. Circulation. 2013;128(2):141–51.

    Article  CAS  PubMed  Google Scholar 

  112. Shaw JA, Andrianopoulos N, Duffy S, Walton AS, Clark D, Lew R, Sebastian M, New G, Brennan A, Reid C, Ajani AE, Melbourne Interventional Group. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Cardiovasc Revasc Med. 2008;9(4):218–23.

    Article  PubMed  Google Scholar 

  113. Sarzaeem MR, Mandegar MH, Roshanali F, Vedadian A, Saidi B, Alaeddini F, Tabarestani N. Scoring system for predicting saphenous vein graft patency in coronary artery bypass grafting. Tex Heart Inst J. 2010;37(5):525–30.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, “Acad. Vasile Candea” Army’s Center for Cardiovascular Diseases, Professor of Cardiology “Titu Maiorescu”, and “Carol Davila” University of Medicine, Bucharest, Romania

    Ion C. Ţintoiu MD, PhD, FESC

  2. Department of Cardiology, Emergency Institute of Cardiovascular Diseases “Prof. Dr. C. C. Iliescu”, Bucharest, Romania

    Ecaterina Bontaş MD, MSc

  3. Department of Cardiology, “Vasile Cândea” Army’s Center for Cardiology, Bucharest, Romania

    Gabriel Cristian MD, PhD, FESC

  4. Department of Cardiovascular Surgery, “Vasile Cândea” Army’s Center for Cardiology, Bucharest, Romania

    Iancu Mocanu MD, PhD

  5. Department of Cardiovascular Surgery, “Vasile Goldis” Western University of Arad, Arad, Arad, Romania

    Francisca Blanca Călinescu MD, PhD

  6. Department of Cardiology, Center Hospitalier de Coutances, Coutances Cedex, France

    Ambrose S. Kibos MD, PhD

Authors
  1. Ion C. Ţintoiu MD, PhD, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ecaterina Bontaş MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gabriel Cristian MD, PhD, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Iancu Mocanu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francisca Blanca Călinescu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ambrose S. Kibos MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ecaterina Bontaş MD, MSc .

Editor information

Editors and Affiliations

  1. Cardiology, Army's Center for Cardiovascular Di, Bucharest, Romania

    Ion C. Ţintoiu

  2. Department of Surgery, Chinese University of Hong Kong, Sha Tin, Hong Kong

    Malcolm John Underwood

  3. University Fribourg, Hospital HFR Fribourg, Fribourg, Fribourg, Switzerland

    Stephane Pierre Cook

  4. Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan

    Hironori Kitabata

  5. University Medical Center, Texas Tech Univ. Health Science Center, EL PASO, Texas, USA

    Aamer Abbas

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ţintoiu, I.C., Bontaş, E., Cristian, G., Mocanu, I., Călinescu, F.B., Kibos, A.S. (2016). Current Risk Scores for the Establishment of the Best Myocardial Revascularization Methods. In: Ţintoiu, I., Underwood, M., Cook, S., Kitabata, H., Abbas, A. (eds) Coronary Graft Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-26515-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26515-5_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26513-1

  • Online ISBN: 978-3-319-26515-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation